## MCO: Moody's Corporation - XLF: Financial Services

### Executive Summary

No thesis match: MRS_20 -1.7% below STRENGTH zone (4.0-10.0%); PEG 2.02 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-1.9% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($467.61)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Arrow Capital Pty Ltd Acquires New Holdings in Moody's Corporation $MCO**
- Source: MarketBeat | 20251210T083141 | Bullish | Relevance: 99%
- Arrow Capital Pty Ltd has acquired a new position in Moody's Corporation (NYSE:MCO) by purchasing 5,000 shares valued at approximately $2.51 million, making it their 27th-largest holding. Moody's recently surpassed quarterly earnings expectations and provided strong FY2025 guidance, while analysts maintain a "Moderate Buy" rating with an average price target of $543.07. Despite institutional investors owning a significant portion of shares, CEO Robert Fauber recently sold some of his holdings.

**2. Moodyâ€™s upgrades Lumexa Imaging to B2 following successful IPO**
- Source: Investing.com | 20251211T230856 | Bullish | Relevance: 99%
- Moody's Ratings has upgraded Lumexa Imaging, Inc.'s corporate family rating to B2 from B3, with a positive outlook, following a successful initial public offering that generated approximately $435 million in net proceeds. The company plans to use these funds to significantly reduce its existing debt and improve its financial metrics. This upgrade reflects a material improvement in credit metrics and Moody's expectation of continued leverage reduction and strong free cash flow generation.

**3. 3 Reasons We Love Moody's (MCO)**
- Source: Finviz | 20251210T230500 | Bullish | Relevance: 99%
-  Moody's (MCO) presents an interesting investment opportunity despite recent underperformance against the S&P 500. The company shows encouraging short-term revenue growth, with annualized revenue growth of 14.5% over the last two years, and spectacular EPS growth of 22.3% over the same period. Additionally, Moody's boasts a stellar average return on equity (ROE) of 63.8% over the last five years, far exceeding the sector average, indicating a strong competitive moat.

**4. Moody's Corporation $MCO Shares Sold by State Street Corp**
- Source: MarketBeat | 20251210T115541 | Somewhat-Bullish | Relevance: 99%
- State Street Corp reduced its holdings in Moody's Corporation (NYSE:MCO) by 1.0% during the second quarter, selling 72,986 shares and retaining 7,144,852 shares valued at $3.58 billion. Despite this sale, other institutional investors like Norges Bank and Vanguard Group Inc. significantly increased their positions in Moody's. The company reported strong Q3 earnings, surpassing analyst estimates, and announced a quarterly dividend of $0.94.

**5. Axa S.A. Raises Position in Moody's Corporation $MCO**
- Source: MarketBeat | 20251211T084905 | Somewhat-Bullish | Relevance: 98%
- Axa S.A. increased its stake in Moody's Corporation (NYSE:MCO) by 43.8% in the second quarter, bringing its holdings to 43,286 shares valued at $21.71 million. Other institutional investors like Hsbc Holdings PLC, Fiera Capital Corp, and Nordea Investment Management AB also adjusted their positions in Moody's. The company's stock shows a market cap of $85.51 billion, a P/E ratio of 38.53, and a consensus price target of $543.07 from analysts.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 5 ($0.21M) |
| Sells | 6 ($0.88M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 51.4% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 6 |

**Top Holders:**
- Berkshire Hathaway, : 13.8% (0.0%)
- Vanguard Group Inc: 8.5% (+1.1%)
- Blackrock Inc.: 8.2% (-3.0%)
- TCI Fund Management : 7.5% (+0.5%)
- State Street Corpora: 4.0% (-0.1%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-1.9% 5d) with bearish MACD, trend may be turning.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.02 elevated, pricing in significant growth expectations. Forward P/E 29.7x stretched relative to 11% growth. Quality metrics strong (ROE 55%, ROA 13%, margin 30%). Institutional flow bearish (6 selling vs 3 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $87.1B |
| Beta | 1.45 |
| 52W Range | $378.71 - $531.93 |
| Short Interest | 1.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.02 |
| Forward P/E | 29.7 |
| Current P/E | 33.1 |
| YoY Growth | 11.2% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from 0.2% to -1.7% (-1.9% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.7pp (needs >4.0% for momentum thesis). Underperforming sector by 3.5pp, stock-specific weakness. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 50. Elevated volume (1.6x 20MA), institutional activity likely.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.73% (CS: 33) | Neutral |
| RSI_14 | 50.3 | Neutral |
| MACD Histogram | -0.10 | Bearish |
| vs SMA20 | 1.004x | Above |
| vs SMA50 | 1.004x | Above |
| vs SMA200 | 1.008x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $485.51
- **Stop Loss:** $467.61 (3.7% risk)
- **Target:** $503.41 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 77
- **Position Value:** $37,384.27
- **Portfolio %:** 37.38%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-12 (Est: $3.37)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.68 | $3.92 | +6.4% |
| 2025Q2 | $3.39 | $3.56 | +5.0% |
| 2025Q1 | $3.54 | $3.83 | +8.2% |
| 2024Q4 | $2.58 | $2.62 | +1.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*